PMID- 23676359 OWN - NLM STAT- MEDLINE DCOM- 20130916 LR - 20171116 IS - 1527-9995 (Electronic) IS - 0090-4295 (Linking) VI - 82 IP - 1 DP - 2013 Jul TI - The prevalence and predictors of androgen deficiency in Taiwanese men with type 2 diabetes. PG - 124-9 LID - S0090-4295(13)00390-7 [pii] LID - 10.1016/j.urology.2013.03.023 [doi] AB - OBJECTIVE: To evaluate the prevalence and predictors of androgen deficiency (AD) in Taiwanese men with type 2 diabetes mellitus (T2DM). METHODS: A recent hospital-based series of Western populations showed that 30%-50% of men with T2DM have low testosterone, and AD links to DM and obesity bidirectionally. However, data of AD from other ethnicities with character of less obesity are rarely reported. AD was defined as having a total testosterone level less than 300 ng/dL. The clinical variables and diabetes-associated complications of the risk of AD were evaluated. RESULTS: Of 766 consecutive subjects (mean age 62.2 years, mean body mass index [BMI] 26.0) attending out-patient diabetic clinics, 32.5% have AD. The AD group was older, had higher BMI, waist circumference, higher proportion of metabolic syndrome and stroke, higher levels of triglyceride, high sensitivity C-reactive protein (hsCRP), uric acid, and lower levels of total cholesterol, high-density lipoprotein (HDL), and low-density lipoprotein (LDL) than the normal testosterone group. After age adjustment, AD was positively associated with metabolic syndrome (odds ratio [OR] = 2.142), serum high sensitivity C-reactive protein (OR = 1.120), uric acid (OR = 1.118), BMI (OR = 1.083), waist circumference (OR = 1.038), triglyceride (OR = 1.028), and inversely associated with serum low-density lipoprotein (OR = 0.931) and high-density lipoprotein (OR = 0.826) in logistic regression analysis. There were no significant differences in retinopathy, neuropathy, nephropathy, or coronary artery disease between patients with or without AD. CONCLUSION: One third of Taiwanese men with T2DM have AD. The major predictors of AD are linked to obesity, which is a potentially modifiable risk factor, and may represent an important avenue for intervention. CI - Copyright (c) 2013 Elsevier Inc. All rights reserved. FAU - Liu, Rue-Tsuan AU - Liu RT AD - Chang Gung University College of Medicine, Taiwan. FAU - Chung, Min-Shen AU - Chung MS FAU - Wang, Pei-Wen AU - Wang PW FAU - Chen, Chung-Dar AU - Chen CD FAU - Lee, Jong-Jer AU - Lee JJ FAU - Lee, Wei-Chia AU - Lee WC FAU - Chancellor, Michael B AU - Chancellor MB FAU - Yang, Kuender D AU - Yang KD FAU - Chuang, Yao-Chi AU - Chuang YC LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20130512 PL - United States TA - Urology JT - Urology JID - 0366151 RN - 0 (Lipoproteins, HDL) RN - 0 (Lipoproteins, LDL) RN - 0 (Triglycerides) RN - 268B43MJ25 (Uric Acid) RN - 3XMK78S47O (Testosterone) RN - 9007-41-4 (C-Reactive Protein) RN - 97C5T2UQ7J (Cholesterol) SB - IM MH - Age Factors MH - Aged MH - Body Mass Index MH - C-Reactive Protein/metabolism MH - Cholesterol/blood MH - Cross-Sectional Studies MH - Diabetes Mellitus, Type 2/*epidemiology MH - Humans MH - Lipoproteins, HDL/blood MH - Lipoproteins, LDL/blood MH - Logistic Models MH - Male MH - Metabolic Syndrome/epidemiology MH - Middle Aged MH - Odds Ratio MH - Prevalence MH - Taiwan/epidemiology MH - Testosterone/blood/*deficiency MH - Triglycerides/blood MH - Uric Acid/blood MH - Waist Circumference EDAT- 2013/05/17 06:00 MHDA- 2013/09/17 06:00 CRDT- 2013/05/17 06:00 PHST- 2013/02/05 00:00 [received] PHST- 2013/03/06 00:00 [revised] PHST- 2013/03/12 00:00 [accepted] PHST- 2013/05/17 06:00 [entrez] PHST- 2013/05/17 06:00 [pubmed] PHST- 2013/09/17 06:00 [medline] AID - S0090-4295(13)00390-7 [pii] AID - 10.1016/j.urology.2013.03.023 [doi] PST - ppublish SO - Urology. 2013 Jul;82(1):124-9. doi: 10.1016/j.urology.2013.03.023. Epub 2013 May 12.